glp-1 and mood The Role of Medications in Psychiatry GLP-1 receptor agonists, such as semaglutide, liraglutide, tirzepatide, have emerged as valuable adjuncts in psychiatry due to their ability to promote weight loss and GLP-1 Glow Up Pack –

Patients should never attempt to manipulate prefilled pens to achieve microdoses, as this risks dosing errors and contamination

Cardiovascular actions of incretin-based therapies

Clinical evidence supports modest improvements in hair density and thickness with consistent use, typically three to four sessions per week for 15-25 minutes each

Martin evaluates each patients health goals, medical history, and potential risks to determine whether microdosing GLP-1 is an appropriate strategy

This success led to the development of exenatide, the first GLP-1 receptor agonist approved by the FDA for the treatment of diabetes (in 2004)